Electrophysiology & Cardiac Ablation Devices Market Size, Share & Analysis | Global | 2019-2025 | MedCore | Segmented by: Type (Conventional, Advanced EP Catheters) & Method (RF Ablation, Cryoablation Catheter)
- Year: 2019
- Scope: 10 Years
- Region: Global
- Type: MedCore
The global diagnostic electrophysiology catheter market size is estimated to increase over the forecast period to exceed $2,911.1 million in 2025. The global cardiac ablation catheter market size is expected to reach over $3,474.5 million in 2025.
The majority of the global diagnostic electrophysiology (EP) catheter market share was controlled by Biosense Webster. This global market research includes conventional EP catheters and advanced EP catheters analyzed as a combined market segment.
The global cardiac ablation catheter market share was also controlled by Biosense Webster. The analysis includes radiofrequency (RF) cardiac ablation catheters and cryoablation catheters. As a result of recent approval decisions, transcatheter ablation procedures will increase in North America and across Europe, driving growth for diagnostic procedures and device usage as well and creating ripple effects across the global EP diagnostic catheter and cardiac ablation markets.
Market Data Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Volumes
- Market Drivers & Limiters
- Market Forecasts Until 2026, and Historical Data to 2016
- Recent Mergers & Acquisitions
- Disease Overviews
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
Diagnostic Electrophysiology Catheter Market Insights
In 2018, the second-fastest-growing segment was the EP diagnostic catheter device market, which increased at a moderate rate over the previous year. The number of ablation devices sold is closely tied to the number of procedures. Therefore, demand is heavily dependent on the number of procedures being performed.
Cardiac Ablation Catheter Market Insights
In 2018, the fastest-growing segment of the cardiac rhythm management, electrophysiology and ablation market was the cardiac ablation catheter market. This segment grew at a high-single-digit rate from the previous year, due to increased adoption of advanced ablation and cryoablation devices. The high average selling price of these products also bolstered market growth. Over the forecast period, the cardiac ablation catheter market is expected to be the fastest-growing segment.
Market Share Insights
The global global diagnostic EP and cardiac ablation catheters market was controlled by Biosense Webster.
Biosense Webster competed solely in the EP and cardiac ablation markets, where it held commanding market-leading positions. The company offers the CARTO®3 3D mapping and EP recording system, SmartAblate® RF ablation generator and remote steering systems and the nMARQ® RF ablation generator.
Accompanying these EP lab systems is a wide portfolio of EP diagnostic catheters and cardiac ablation catheters. Some of the notable product names are the AcuNav™ and CARTO SOUNDSTAR™ ultrasound catheters, the LASSO® advanced EP recording catheters, and the WEBSTER® line of fixed and steerable conventional EP catheters. More details on product development and the competitive landscape including new product launches and main challenges are described in details on this report.
Research Regional Coverage
Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
| Biosense Webster |
| Medtronic |
| Boston Scientific |
| Abbott |
| Biotronik |
| Others |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Electrophysiology & Cardiac Ablation Devices Market Size, Share & Analysis | Global | 2019-2025 | MedCore | Segmented by: Type (Conventional, Advanced EP Catheters) & Method (RF Ablation, Cryoablation Catheter)
$4,995 – $8,995
This global market research includes conventional EP catheters and advanced EP catheters analyzed as a combined market segment. The analysis also covers radiofrequency (RF) cardiac ablation catheters and cryoablation catheters.
- 2019
- 10 Years
- Global
- MedCore
Related Reports
